Cardiac performance in infants after repair of total anomalous pulmonary venous connection.
D001794:Blood Pressure; D002245:Carbon Dioxide / Q000097:blood; D006328:Cardiac Catheterization; D002302:Cardiac Output; D003452:Cryosurgery; D004077:Digoxin / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006221:Halothane / Q000627:therapeutic use; D006321:Heart / Q000503:physiopathology*; D006324:Heart Arrest, Induced; D006330:Heart Defects, Congenital / Q000503:physiopathology / Q000601:surgery*; D006439:Hemodynamics; D006454:Hemoglobins; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007223:Infant; D007231:Infant, Newborn; D007545:Isoproterenol / Q000627:therapeutic use; D007565:Jaundice / Q000209:etiology; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption; D011182:Postoperative Care; D011183:Postoperative Complications; D011667:Pulmonary Veins / Q000002:abnormalities* / Q000601:surgery; D012044:Regression Analysis
D006454:Hemoglobins; D002245:Carbon Dioxide; D004077:Digoxin; D005665:Furosemide; D007545:Isoproterenol; D010100:Oxygen; D006221:Halothane; D004837:Epinephrine